Regulation & law · 22/10/2020

National Cancer Institute to Grant Exclusive Patent License to Six Therapeutics for Topical Ointment

The National Cancer Institute, part of the National Institutes of Health, Department of Health and Human Services, is considering granting an exclusive patent license to Six Therapeutics Technologies Holdings Group, a New Jersey-based company, to develop a topical ointment containing immunostimulatory CpG Oligodeoxynucleotides (ODN) for dermatological wound healing.